Cinnarizine


Generic Medicine Info
Administration
Should be taken with food.
Special Precautions
Patient with hypotension (high dose), Parkinson's disease and porphyria. Children. Pregnancy and lactation. Patient Counselling This drug may cause drowsiness, if affected, do not drive or operate machinery.
Adverse Reactions
Significant: Epigastric discomfort. Gastrointestinal disorders: Nausea, dyspepsia, vomiting, upper abdominal pain, gastrointestinal discomfort. General disorders and administration site conditions: Fatigue, lethargy. Hepatobiliary disorders: Cholestatic jaundice. Investigations: Increased weight. Musculoskeletal and connective tissue disorders: Muscle rigidity. Nervous system disorders: Dyskinesia, extrapyramidal disorder, Parkinsonism, tremor, drowsiness, somnolence. Skin and subcutaneous tissue disorders: Hyperhidrosis, lichenoid keratosis (e.g. lichen planus), subacute cutaneous lupus erythematosus.
Drug Interactions
May potentiate sedative effects of CNS depressants and TCAs.
ATC Classification
N07CA02 - cinnarizine ; Belongs to the class of antivertigo preparations.
Disclaimer: This information is independently developed by CIMS based on cinnarizine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in